MULTAQ is provided as tablets for oral administration. Each tablet of MULTAQ contains 400 mg of dronedarone (expressed as base). The inactive ingredients are: Core of the tablets-hypromellose, starch, crospovidone, poloxamer 407, lactose monohydrate, colloidal silicon dioxide, magnesium stearate. ...
部份中文盐酸决奈达隆处方资料(仅供参考)商品名:MULTAQ 400MG英文名:Dronedarone中文名:盐酸决奈达隆药理类别:Class III孕妇用药分级X 级:不论是动物或人体的研究试验中均显示该药物对胚胎有不良影响,且此药物对怀孕妇女所产生的效益很低,则此药对妊娠妇女或可能怀孕的妇女为禁忌使用。结构式Dronedarone HCl 是benzofur...
Dronedarone Hydrochloride Routes Dosage Forms Strengths Brand Names Manufacturer Oral Tablets, film-coated 400 mg (of dronedarone) Multaq Sanofi-Aventis AHFS DI Essentials™. © Copyright 2025, Selected Revisions June 2, 2016. American Society of Health-System Pharmacists, Inc., 4500 East-West ...
交易:DRONEDARONE400MG TABLETS/ DA40 - FOC SAMPLE, VALUE SHOWN FOR CUSTOM PURPOSE ONLY ( EACH PACK CONTIAN 180 TABLETS ) 数据已更新至2024-11-30 有联系方式emcure pharmaceutical usa inc. india|27505笔交易 活跃值87 交易:MULTAQ (DRONEDARONETABLETS,400 MG) QTY 10 X 10 = 100 TABLETS TEST LIC ...
Dronedarone (also known as SR33589 and marketed as Multaq) is a drug by Sanofi-Aventis, mainly for the indication of cardiac arrhythmias (irregular heartbeat). It was approved by the FDA on July 2, 2009. It is now available as 400 mg tablets in 60 count bottles.关键词:...
Sanofi—Aventis公司宣布Multaq(dronedarone,决奈达隆)(Ⅰ)(400mg片剂)已获加拿大卫生部批准用于既往或目前患有房颤患者的治疗以降低因其入院的风险. - 《国外药讯》 被引量: 0发表: 2009年 治疗房颤的新型药物屈奈达隆 房颤是最常见的心律失常病症,其发病率随着年龄的增长而提高.胺碘酮(Amiodarone)是治疗房颤的最...